USPTO serial 90132747
FORMEDIX RYZE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 14, 2021
- Examiner
- BURCH, JILLIAN RENEE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with FORMEDIX RYZE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*
Plus Government fees of $975
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Carrie Webb Olson
Carrie Webb Olson DAY PITNEY LLPOne Federal Street - 29th FloorBoston, MA 02110United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | On-line retail ordering services featuring clinical metadata management computer software for use in relation to clinical trials, clinical management computer software for use in relation to clinical trials, computer software for use in exclusively collecting, storing, controlling, managing and submitting of clinical metadata and clinical data in relation to clinical trials, database management computer software for use exclusively in relation to clinical trials, computer software to allow users to collect, store, control, manage and submit clinical metadata and clinical data in relation to clinical trials, computer databases for collecting, storing, controlling, managing and submitting clinical data in relation to clinical trials, computer software designed to ensure that clinical metadata and clinical data meets the regulations and standards required by international and government agencies in relation to clinical trials, computer software used by pharmaceutical companies, biotechnology companies, medical device manufacturers, and contract research organizations to help collect the required clinical data and meet the required standards for data collection, tabulation, analysis, and submission for clinical trials, all of the aforesaid computer software being used in relation to clinical trials only | ACTIVE | — |
| 041 | Providing training services to enable pharmaceutical companies, biotechnology companies, medical device manufacturers, and contract research organizations to use clinical metadata management software platforms for managing clinical trial metadata and clinical trial data; providing training services to enable pharmaceutical companies, biotechnology companies, medical device manufacturers, and contract research organizations to collect the required clinical data and meet the regulations and standards required by international and government agencies for data collection, tabulation, analysis, and submission for clinical trials; providing training services in relation to the use of clinical metadata management computer software for use in relation to clinical trials; providing training services in relation to the use of clinical management computer software for use in relation to clinical trials; all of the aforesaid training services being used in relation to clinical trials only | ACTIVE | — |
| 042 | Providing temporary use of on-line non-downloadable clinical metadata management computer software for use in relation to clinical trials; providing temporary use of on-line non-downloadable clinical management computer software for use in relation to clinical trials; providing temporary use of on-line non-downloadable computer software for use in exclusively collecting, storing, controlling, managing and submitting of clinical metadata and clinical data in relation to clinical trials; providing temporary use of on-line non-downloadable database management computer software for use exclusively in relation to clinical trials; providing temporary use of on-line non-downloadable computer software to allow users to collect, store, control, manage and submit clinical metadata and clinical data in relation to clinical trials; providing on-line computer databases for collecting, storing, controlling, managing and submitting clinical data in relation to clinical trials; providing temporary use of on-line non-downloadable computer software designed to ensure that clinical metadata and clinical data meets the regulations and standards required by international and government agencies in relation to clinical trials; providing temporary use of on-line non-downloadable computer software used by pharmaceutical companies, biotechnology companies, medical device manufacturers, and contract research organizations to help collect the required clinical data and meet the required standards for data collection, tabulation, analysis, and submission for clinical trials; design and development of computer software exclusively for managing clinical metadata and clinical data in clinical trials; designing, creating and maintaining web pages exclusively in connection with collecting, storing, controlling and managing clinical metadata and clinical data, to meet the regulations and standards required by international and government agencies in conducting clinical trials; all of the aforesaid software services being used in relation to clinical trials only; technical support services, namely, troubleshooting of computer software problems related to clinical metadata management software platforms for managing clinical trial metadata and clinical trial data; providing medical and scientific research information in the field of clinical trials to enable pharmaceutical companies, biotechnology companies, medical device manufacturers, and contract research organizations to collect the required clinical data and meet the regulations and standards required by international and government agencies for data collection, tabulation, analysis, and submission for clinical trials; technical support services, namely, troubleshooting of computer software problems related to clinical metadata management computer software for use in relation to clinical trials; technical support services, namely, troubleshooting of computer software problems related to clinical management computer software for use in relation to clinical trials; all of the aforesaid information and support services being used in relation to clinical trials only | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Formedix Limited
- Other trademarks owned by Formedix Limited
- Other trademarks owned by Formedix Limited
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named FORMEDIX RYZE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 14, 2026 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| May 7, 2025 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| May 7, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 7, 2025 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| May 7, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 7, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 7, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 7, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Sep 14, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 12, 2021 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Aug 12, 2021 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Aug 3, 2021 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Aug 3, 2021 | D1BR | TEAS DELETE 1(B) BASIS RECEIVED | — |
| Jul 27, 2021 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 1, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 1, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 12, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 23, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 22, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 22, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 22, 2021 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Apr 20, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 20, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 20, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 29, 2021 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Mar 29, 2021 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Mar 9, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 9, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 3, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 22, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 22, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 22, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 21, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 2, 2020 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Nov 30, 2020 | ALIE | ASSIGNED TO LIE | — |
| Sep 25, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 14, 2020 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Aug 27, 2020 | NWAP | NEW APPLICATION ENTERED | — |